Almost 800 researchers, clinicians, industry partners, policymakers and further stakeholders from 36 countries attended the LifeTime Conference 2.0 on June 16 & 17 which took place as a virtual event. The goal of the pan-European LifeTime Initiative, which had its Opening Conference two years ago in Berlin, is to understand Read more…
Improving European healthcare through cell-based interceptive medicine Hundreds of innovators, research pioneers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare. In two publications – a perspective article in the journal Natureand the LifeTime Strategic Research Agenda – they Read more…
Human Cell Atlas – LifeTime Joint Statement Human Cell Atlas (HCA) and LifeTime are joining efforts to contribute to the fight against the COVID-19 pandemic. Together, we are creating a common framework for openly sharing knowledge, tools, data, and other resources. This aims to enable in-depth analyses of the SARS-CoV-2 Read more…
COVID-19: Immune system derails A severe course of COVID-19 does not solely result in a strong immune reaction – rather, the immune response is caught in a continuous loop of activation and inhibition. This is reported in Cell by experts of the nationwide deCOI research network, including colleagues at the Read more…
Ahead of the European Council negotiations on the next Multiannual Financial Framework, academic and industry leaders supporting the LifeTime initiative, have called members of the European Union into action. They ask to preserve the existing Horizon Europe budget and put forward ten recommendations to strengthen EU health research. Europe needs significant, coordinated and balanced investment programs to Read more…
LifeTime at Berlin Science Week We look forward to 3 exciting events with LifeTime during the Berlin Science Week that will take place from 1-10 November 2019. Interactive formats of The Science Slam of a LifeTime – “I know something that you don’t know” and Mind the Lab will bring Read more…
New perspectives for LifeTime LifeTime and the European Commission have initiated high-level strategic discussions to implement LifeTime’s vision and to fulfil the EC’s priorities for digital and data-driven medicine. Beginning of July, the coordinators of LifeTime, Nikolaus Rajewsky and Geneviève Almouzni, met with director general of DG CNECT, Roberto Viola. Read more…
Experts identify the potential ethical, legal and societal aspect of the LifeTime Initiative On 10 July, Helmholtz Stem Cell Center in Munich hosted the LifeTime Ethics Stakeholder Workshop with the aim to identify the potential ethical, legal and societal issues (ELSI) raised by the development of LifeTime technologies: single cell, Read more…
LifeTime is pleased to welcome new academic institutions and research centers as Associated Partners of the Consortium. In June 2019, LifeTime launched a call for Associated Partners to join the Initiative. Over 70 institutions, many of which were not previously connected to the initiative, have already responded and are now Read more…
LifeTime has launched the call for the institution in Europe to become Associated Partners in the consortium. The Associated Partners can support LifeTime activities, elect two representative members in the Steering Board, and participate in the work packages, working groups, task forces, attend meetings to shape the future of Lifetime Read more…